Abstract
Severe pseudomembranous colitis was observed in 3 members of a single family: the father and 2 of his children. 2 of the affected family members received the antibiotic lincomycin prior to the onset of their symptoms. The findings in this family raise the possibility that antibiotic-induced pseudomembranous colitis in some patients may be the result of a pharmacogenetic interaction.
Similar content being viewed by others
References
Ecker JA, Williams RG, McKittrick JE, Failing RM: Pseudomembranous enterocolitis—An unwelcome gastrointestinal complication of antibiotic therapy. Am J Gastroenterol 54:214–228, 1970
Benner EJ, Tellman WH: Pseudomembranous colitis as a sequel to oral lincomycin therapy. Am J Gastroenterol 54:55–58, 1970
Pittman FE, Pittman JC: Lincomycin colitis. Gastroenterology 58:983, 1970
Manashil GB, Kern JA: Nonspecific colitis following oral lincomycin therapy. Am J Gastroenterol 60:394–399, 1973
Schapiro RL, Newman A: Acute enterocolitis: A complication of antibiotic therapy. Radiology 108:263–268, 1973
Scott AJ, Nicholson GI, Kerr AR: Lincomycin as a cause of pseudomembranous colitis. Lancet 2:1232–1324, 1973
Cohen LE, McNeil CJ, Wells RF: Clindamycin-associated colitis. JAMA 223:1379–1380, 1973
Stroehlein, JR, Sedlack RE, Hoffman HN, Newcomer AD: Clindamycin-associated colitis. Mayo Clin Proc 49:240–243, 1974
Tedesco FJ, Stanley RJ, Alpers DH: Diagnostic features of clindamycin-associated pseudomembranous colitis. N Engl J Med 290:841–843, 1974
Wells RF, Cohen LE, McNeill CJ: Clindamycin and pseudomembranous colitis. Lancet 1:66, 1974
Wise R, Tudway AJC, Pelta DE: Clindamycin and pseudomembranous colitis. Lancet 1:878–879, 1974
Steer HW: Pseudomembranous colitis associated with clindamycin. Lancet 1:1176, 1974
Goulston SJM, McGovern VJ: Pseudo-membranous colitis. Gut 6:207–212, 1965
Henigar GR, Drug and chemical injury. Pathology, Vol. 1. WAD Anderson (ed). St. Louis, The C V Mosby Company, 1971, pp 179–180
Singer HC, Anderson JGD, Frischer H, Kirsner JB: Familial aspects of inflammatory bowel disease. Gastroenterology 61:423–430, 1971
Author information
Authors and Affiliations
Additional information
Supported by grants from the National Institutes of Health (GM 19258) and from the Upjohn Co. Dr. Brown is an Established Investigator of The American Heart Association. Dr. Goldstein is the recipient of USPHS Research Career Development Award 5 KO4 GM 70277.
Rights and permissions
About this article
Cite this article
Harrod, M.J.E., Brown, M.S., Weinberg, A.G. et al. Familial pseudomembranous colitis and its relation to lincomycin therapy. Digest Dis Sci 20, 808–812 (1975). https://doi.org/10.1007/BF01070948
Issue Date:
DOI: https://doi.org/10.1007/BF01070948